Luxembourg vs Norway: Avoidable mortality
Avoidable mortality over time
- Luxembourg
- Norway
How they compare
Norway currently reports 8,381 Deaths against 810 Deaths in Luxembourg, a difference of 7,571 Deaths.
That makes Norway's figure about 10.3 times Luxembourg's.
Across all 17 years both countries report, Norway has been ahead every year.
Luxembourg ranks 35th and Norway ranks 34th of 36 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Luxembourg | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1,002 Deaths | 8,960 Deaths | 7,957 Deaths | Norway |
| 2010s | 876.86 Deaths | 8,365 Deaths | 7,488 Deaths | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher avoidable mortality, Luxembourg or Norway?
- Norway, at 8,381 Deaths against 810 Deaths in Luxembourg as of 2016.
- What is the difference in avoidable mortality between Luxembourg and Norway?
- 7,571 Deaths, with Norway ahead.
- How many years of comparable data are there for Luxembourg and Norway?
- 17 years are reported by both, from 2000 to 2016.
- How do Luxembourg and Norway rank globally for avoidable mortality?
- Luxembourg ranks 35th and Norway ranks 34th of 36 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Avoidable mortality. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents data on preventable, treatable and avoidable (preventable + treatable) causes of mortality. Preventable and treatable causes of mortality are defined as follows: - Preventable mortality: Causes of death that can be mainly avoided through effective public health and primary prevention interventions (i.e. before the onset of diseases/injuries, to reduce incidence). - Treatable (or amenable) mortality: Causes of death that can be mainly avoided through timely and effective healthcare interventions, including secondary prevention such as screening, and treatment (i.e. after the onset of diseases, to reduce case-fatality). Both indicators refer to premature mortality (under age 75). Please refer to the Sources and Methods for detailed country-specific information.